Approval · Notice of Compliance 29700 · 2022
CTP 30: Notice of Compliance 29700
Issued December 13, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29700
- Date
- December 13, 2022
- Company
- Sunovion Pharmaceuticals Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Administrative: Labelling Update (to Match Licensor)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CTP 30 | Not yet assigned | — |
Medicinal ingredients
- CITALOPRAM HYDROBROMIDE 30 MG per TAB